Alpha-1-antitrypsin deficiency asthma and allergy

European Annals of Allergy and Clinical Immunology

Volumn 39, Issue 4, 2007, Pages 127-132

  Palma Carlos, A G ^a   Palma Carlos, M L ^a  

^a Clinical Allergy Immunology Center CAIC   (Portugal)

Author keywords

Allergy; Alpha 1 anti trypsin; Asthma; COPD

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; STEROID;

ALLERGY; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; ELECTROPHORESIS; GEOGRAPHIC DISTRIBUTION; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIVER DISEASE; LUNG FUNCTION; PHENOTYPE; PROTEIN ANALYSIS; SMOKING; SMOKING CESSATION; VACCINATION;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ASTHMA; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34248342304     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Alpha-1 Antitrypsin Deficiency Registry Study Group: Survival and FEV1 decline in individuals with severe deficiency of Alpha-1 antitrypsin. Am J Resp Crit Care Med 1998;158:49-59.
2. Alpha-1-antitrypsin deficiency Memorandum from a WHO meeting. Bull World Health Organ 1997;75:397-415.
3. Alvarez-Ganda., Cabero-Perth M.-J., Bustamante-Ruiz et al. - Pi SZ phenotype in dynamic obstructive pulmonary disease. Thorax 1997;52:659-661.
4. Arora P.-K., Miller M.-C. - Alpha-1 antitrypsin is an effector of immunological stasis. Nature 1987;174:589-595.
5. Blanco F., Fernandez E., Bustillo E.-F. - Alpha-1 antitrypsin Pi Phenotypes S and Z in Europe: analysis of the published surveys. Clin Genet 2001;60:31-41.
6. Blumenthal M.-N. - Genetics of asthma, allergy and related conditions in Genetics of Allergy and Asthma Blumenthal MN, Björksten B (eds) Marcel Dekker, New York, 1997;327-356.
7. Bruce R.-M., Cohen B.-H., Diamond E.-L. et al. -Collaborative study to assess risk of lung disease in Pi MZ Phenotype subjects. Am Rev Respir Dis 1984;118:649-652.
8. Carrell R.-W. - What we owe to alpha-1-antitrypsin and to Carl Bertil Laurell J. COPD 2004;1:71-84.
9. Carp H., Janoff A. - Possible mechanisms of emphysema in smokers. "In vivo" suppression of serum elastase - inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 1978;118:617-621.
10. Carp H., Janoff A. - "In vitro" suppression of serum elastase inhibitory capacity by reactive oxygen species. J Clin Invest 1979;63:793-797.
11. Colp C.-R., Lieberman J. - Asthma and Alpha-1 antitrypsin in Bronchial Asthma Weiss EB., Stein MY (eds) Little Brown and Company, Boston, 1993;1185-1187.
12. Crystal R.-G., Brantly M.-L., Hubbard R.-C., Duriel D.-T. - The Alpha-1 antitrypsin deficiency in Stanbury JB., Wyngaarden JD., Fredrickson DS., Goldstein JL., Brown MS (eds) The metabolic basis of inherited disease MC Graw-Hill, New York, 1983;1450-146.
13. Dirksen A., Dijkman J.-H., Madsen F. - A randomised clinical trial of alpha-1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-1472.
14. Dowson L.-J., Guest P.-J., Campbell E.-J., Stockley R.-A. - Relationship between chronic bronchitis, emphysema and quality of life in patients with Alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2000;161:A976.
15. Eriksson S. - Studies in Alpha-1 antitrypsin deficiency. Acta Med Scand 1965;177-185.
16. Erikson S., Carlson J., Velez R. - Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1976;294:1316-1321.
17. Eriksson S., Carlson J., Velez R. - Risk of cirrhosis and primary liver cancer in alpha-1 antitrypsin deficiency. N Eng J Med 1986;314:736-739.
18. Eriksson S.-A. - 30-year perspective on Alpha-1 antitrypsin deficiency. Chest 1996;110:237S-242-S.
19. Fagerhol M.-K., Hauge H.-E. - Serum Pi types in patients with pulmonary diseases. Acta Allergol 1969;24:107-115.
20. Gaillard M.-C. et al. - Alpha-1 protease inhibitors in bronchial asthma: phenotypes and biochemical characteristics. Am Rev Respir Dis 1992;145:1311-1318.
21. Gelehrter T.-D., Collins F.-S. - Principles of Medical Genetics Williams and Wilkins, Baltimore, 1990.
22. Global Initiative for chronic obstructive lung disease Global strategy for the diagnosis pulmonary disease, management and prevention of chronic obstructive www. Goldcopie.org. 2006.
23. Hubbard R.-C., Sellers S.-E., Caerski D.-B. - Biochemical efficacy and safety of monthly augmentation therapy for alpha-1-antitrypsin deficiency. JAMA 1988;260:651-658.
24. Janoff A. - Levels of elastase activity in broncho-alveolar lavage fluids of healthy smokers and non-smokers. Am Rev Resp Dis 1983;127-128.
25. Janoff A. - Elastases and emphysema. Current assessment of the proteinase antiproteinase hypothesis. Am Rev Resp Dis 1985;13:417-433.
26. Janus E.-D., Philips N.-T., Carrell R.-W. - Smoking, lung functions and Alpha-1 antitrypsin deficiency. Lancet 1985;1:152-154.
27. Joos L., Pare P.-D., Sandford A.-J. - Genetic risk factors in chronic obstructive lung diseases Voelker NF., MacNee, W (eds) BC Decker Inc.,Hamilton, 2002:56-64.
28. Kueppers F., Black L.-E. - Alpha-1 antitrypsin and its deficiency. Am Rev Respir Dis 1974;110:176-194.
29. Kueppers F., Dommardt A. - Obstructive lung disease in heterozygotes for Alpha-1 antitrypsin deficiency. Ann Intern Med 1974;80:209-212.
30. Lindmark S., Svenonius., Eriksson S. - Heterozygous Alpha-1-antitrypsin and Pi Z alpha-1 antitrypsin deficiency: prevalence and clinical spectrum in asthmatic children. Allergy 1990;45:197-203.
31. Lindmark B. - Asthma and heterozygous Alpha-1 antitrypsin chymotryspin deficiency: a possible association. J Intern Med 1990;227:115-118.
32. Laurell C.-B., Eriksson S. - The electrophoretic Alpha-1 globulin pattern of serum alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-140.
33. Lomas D.-A., Evans D.-L., Finch J.-T. - The mechanisms of Z alpha-1 antitrypsin accumulation in the liver. Nature 1992;357:605-607.
34. Lomas D.-A. - Genetics of COPD in chronic obstructive pulmonary disease Stockley, RA (ed) Current Medicine Group Ltd, London, 2006.
35. Lomas D.-A., Mahadeva R. - Alpha-1-antitrypsin polymerisation and the serpinopathies. J Clin Invest 2002;110:1585-1590.
36. Madaheva R., Lomas D.-A. - Alpha-1-antitrypsin deficiency cirrhosis and emphysema. Thorax 1998;53:501-505.
37. National Heart. - Lung and Blood Institute Global initiative for chronic obstructive lung disease National Institute of Health, Bethesda, MD, 2001.
38. Novoradovsky A., Brantly M. et al. - Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogens of emphysema in alpha-1-antitrypsin deficiency. Am J Resp Cell Mol Biol 1999;20:441-447.
39. Ogushi F., Fells G.-A., Hubbard R.-C et al. - Z type alpha-1-antitrypsin is less competent than M1 type alpha-1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 1987;80:1366-1374.
40. Palma-Carlos A.-G., Palma-Carlos M.-L. - IgG, IgA, IgM and Alpha-1-antitrypsin serum level in allergic patients Excerpta Medica - International Congress series, VIII International Congress of Allergology, Florence 1970.
41. Palma-Carlos A.-G., Palma-Carlos M.-L. - Alpha-1-antitrypsin deficiency in chronic obstructive pulmonary disease and bronchial asthma. Pneumologia 1970;1,:71-178.
42. Palma-Carlos A.-G., Palma-Carlos M.-L. - Dosage des proteins seriques par immunodiffusion radiale en Allergologie Excerpta Medica International Congress Series, VIII Congrès Europeen d'Allergologie, Marseille, 1971.
43. Palma-Carlos A.-G., Palma-Carlos A.-G. - Immunothérapie orale avec lysats bactériens dans l'asthme et infections respiratoires de repetition. Médicine Hygiene 1985;43:2718-2721.
44. Palma-Carlos M.-L., Palma-Carlos A.-G. - Effet immunostimulants de ribosomes bactériens adjuvés par les peptides glycans. Ouest Médical 1982;34:155-158.
45. Parmar J.-S., Mahadeva R., Reed B.-J. - Polymers of alpha-1 antitrypsin are chemotactic for human neutrophils. Am J Respir Cell Med Biol 2002;26:723-730.
46. Pitulainen, Tornling G., Eriksson S. - Effect of age and occupation exposure to airway irritant on lung function is non-smoking individuals with alpha-1-antitrypsin deficiency (Pi ZZ). Thorax 1997;52:244-248.
47. Prados M., Monteseirin F., Carranco M., Aragon R., Conde A., Conde J. - Phenotype of alpha-1 antitrypsin in intrinsic asthma and ASA-triad patients. Allergol Immunopathol 1995;23:24-28.
48. Reid L. - Chronic obstructive lung disease in Pulmonary Diseases and Disorders Fishman AP (ed) McGraw Hill, New York, 1980;503-525.
49. Rennard S.-I., Floreani A. - Pathophysiology of chronic obstructive pulmonary disease in Asthma, Barnes PJ., Grunstein MM., Leff AR., Woolcock AJ (eds) Lippincott-Raven Publishers. Philadelphia, 1997;1375-1388.
50. Santos Rosa M.-A. - Alpha-1 Proteinase inhibitor and deep lung in Pulmão Profundo, Robalo Cordeiro, AJA (ed) Boehringer Ingelheim, Coimbra 1990;59-72.
51. Santos Rosa M.-A., Robalo Cordeiro AJA. - Action of ceruloplasmin on the oxidative inaction of alpha-1 proteinase inhibitor. Eur Resp J 1989;2 sup 8, 665.
52. Seersholm N., Wilcke JTR., Kokjensen A., Dirksen A. - Risk of hospital admission for obstructive pulmonary diseases alpha-1-antitrypsin heterozygotes of phenotype Pi MZ. Am J Respir Crit Care Med 2000;161:81-84.
53. Seersholm N., Wencker M., Banik N. - Does alpha-1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1-antitrypsin deficiency. Eur Respir J 1997;10:2260-2263.
54. Senior R.-M. - Chronic obstructive pulmonary disease in Fishman's Manual of Pulmonary diseases and disorders Fishman AP, Ezias JA, Fishman JA, Grippi MA, Kaisor LR, Senior RM (eds) McGraw Hill, New York, 2002;118-141.
55. Smith S.-F., Guz A., Cooke N.-T., Winning A.-J. - Effect of cigarette smoke on antiproteinases at the human lung surface. Eur J Respir Dis 1986;139-143.
56. Stockley R.-A. - Alpha-1 antitrypsin deficiency in chronic obstructive lung diseases Voelkel NF, MacNee W (eds) BC Dekker Inc., Hamilton, London, 2002;80-89
57. Sveger T. - Liver diseases in alpha-1-antitrypsin deficiency detected by screening of 200.000 infants. N Engl J Med 1976;294:1316-1321.
58. Teckman J.-H., Perlmutter D.-H. - The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha-1-antitrypsin Z and S. J Biol Chem 1996;31:13215-13220.
59. Torino G.-M, Barker A.-F, Brantly M.-L. - Clinical feature of individual Pi SZ phenotype of Alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 1996;154:1718-1725.
60. Townley R.-G. et al. - Association of MS Pi Phenotype with airway hyperresponsiveness. Chest, 1990;95:594-598.
61. Wewers M;-D., Casolaro M.-A., Sellers S.-E. - Replacement therapy for alpha-1-antitrypsin deficiency. N Engl J Med 1987;316:1058-1062.